ISI Group Downgrades Hologic, Saying Turnaround Effort Will Take Time | GenomeWeb

NEW YORK (GenomeWeb News) – Investment firm ISI Group on Wednesday downgraded shares of Hologic, saying the company's new management will need time to turn the business around.

ISI downgraded Hologic's shares to Buy from a previous Strong Buy rating, but maintained earlier EPS estimates of $1.35 for Fiscal Year 2014; $1.55 for FY 2015; and $1.75 for FY 2016.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.